Table 2 Main parameters recorded at baseline and at 6 months with p values for significant paired comparisons

 - Beta-blockers

100 (83%)

101 (84%)

 - ACE inhibitors

103 (85%)

104 (86%)

 - Statins

110 (91%)

105 (87%)

 - Antiplatelet therapy

120 (99%)

115 (95%)

Body mass index (kg.m⁻²)

25 ± 4

25 ± 4

Heart rate (bpm)

66 ± 11

57 ± 8

< 0.001

 Systolic BP (mmHg)

129 ± 21

130 ± 20

 Diastolic BP (mmHg)

75 ± 14

72 ± 11

 Mean BP (mmHg)

93 ± 15

92 ± 13

 LV end-diastolic volume (mL.m⁻²)

92 ± 15

96 ± 18

0.006

 LV ejection fraction (%)

42 ± 8

49 ± 9

< 0.001

 Total MI area (% of LV)

22 ± 12

16 ± 11

< 0.001

 Transmural MI - presence (%)

94 (78%)

55 (46%)

< 0.001

  - area (% of LV)

16 ± 13

8 ± 11

< 0.001

 MVO - presence (%)

59 (49%)

0 (0%)

< 0.001

  - area (% of LV)

8 ± 11

0 ± 0

< 0.001

 SV (mL.m⁻²)

38 ± 8

47 ± 9

< 0.001

 Cardiac index (L.min⁻¹.m⁻²)

2.4 ± 0.4

2.6 ± 0.5

< 0.001

 TPVR (mmHg.min.m².L⁻¹)

39 ± 11

36 ± 9

0.001

 TAC (mL.m⁻².mmHg⁻¹)

0.74 ± 0.21

0.83 ± 0.22

< 0.001

 Ea (mmHg.m².mL⁻¹)

2.6 ± 0.9

2.1 ± 0.6

< 0.001

 Stroke Work (L.mmHg.m⁻²)

3.5 ± 0.9

4.3 ± 1.0

< 0.001